about
HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.Amplification testing in breast cancer by multiplex ligation-dependent probe amplification of microdissected tissue.Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancerESR1 amplification in breast cancer by optimized RNase FISH: frequent but low-level and heterogeneous.Promoter hypermethylation profiling of distant breast cancer metastases.Repeated nipple fluid aspiration: compliance and feasibility results from a prospective multicenter studyClinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinomaHer-2/neu testing and therapy in gastroesophageal adenocarcinoma.Current technologies for HER2 testing in breast cancer.Chromosome 17 polysomy without HER2 amplification does not predict response to lapatinib in metastatic breast cancer--letter.Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes.Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification.Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA.Correction: ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous.Chromosome 17 copy number changes in male breast cancer.Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast.Methylation biomarkers for pleomorphic lobular breast cancer - a short report.CEP17 copy number increase does not indicate polysomy 17.ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes.Implications of rarity of chromosome 17 polysomy in breast cancer.Re: How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.Low frequency of HER2 amplification and overexpression in early onset gastric cancer.Validation of a fully automated HER2 staining kit in breast cancer.HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization.Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.Multiplex ligation-dependent probe amplification to detect HER2 amplification in breast cancer: new insights in optimal cut-off value.Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplificationValidation of DNA promoter hypermethylation biomarkers in breast cancer — a short reportPrognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastasesHER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation?On the evidence for ESR1 amplification in breast cancerFormaldehyde substitute fixatives: effects on nucleic acid preservationESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study
P50
Q33397620-0CCD3702-E2C2-42CE-8FE7-40CB0B7F7729Q33944570-67EA025E-72B5-4EE8-A1EC-6067D1B7409BQ33961869-F4E5C583-0AF5-4072-90CE-65C35DABB012Q34212655-34D31492-23BC-443A-810E-C247843C3FA1Q34584209-E8B6AA51-4D77-439B-891F-C5BD7A3391F1Q34998465-E15C8605-EE10-417B-BDB4-D6B8C477A2C0Q35064067-F1C54655-D5F7-4543-883E-D640CB152DABQ35075706-B0364EA8-11FF-40D8-B683-24F48A657B99Q35533772-070A1CDE-7EFB-4E29-991C-05FCD7161DE4Q35637243-48040E2A-6041-460C-B5A7-02D6EC097A44Q36201478-5952120B-23F7-4BC3-9214-12633C399B9DQ37824265-60F532C8-1164-4C45-9404-922D2BEBAC20Q37832859-3BB25F68-852B-49E5-B6F3-A3AECE2AD174Q42776042-A075070B-4E77-4A03-B385-7280D81CDDF9Q43062153-8786B7F3-2910-4993-A70F-71B843EDFD79Q44460827-7951C1B9-D214-4D8A-A28D-F8EDBD3BE717Q45342178-1C974F6C-03BF-4A9A-BDA9-44D3260385E3Q45853348-AB6EA07E-D8BE-4837-91F5-7CB8D9C14D37Q46760632-21DBCFC9-2763-4347-B603-C598CB489F4DQ54165077-E0EA13EB-0C6D-4E8C-B7C6-E6C99F838518Q54215084-7962C34C-F517-4D5D-9712-CE3B20AFD47BQ54317130-E5048C62-4BA6-48CA-83A6-956C43712903Q54384557-018AF7FF-D4E8-4C61-902E-A422299F49F7Q54405518-ACE30F77-AEFF-40F3-AC4F-2D7C38675D92Q54550048-9DBECD7A-8B04-49A7-A643-A49AEBFFF0C5Q54562078-FAB79E33-F9E0-4448-B5CA-9009B42D5907Q54604074-806BC17A-1D8B-4C94-98FD-E1DBE7FB7A85Q54605374-0E829C9F-88B7-4411-8A69-C0DAC64C562DQ54688784-FB9E49F1-B99C-4DFD-955E-66C67295E501Q54779563-88B693CD-D857-42D5-9895-9FC15E4C99BCQ54838100-D6122F88-756D-42EC-9AEB-22E001DC131DQ55215157-C9A11BB0-3C16-4EBB-ABA5-D18853824705Q55223470-14B6EBA3-C867-4764-A918-C09004CD7970Q60529794-F26417E5-4EE2-4629-8AA9-EFE0942BABABQ60529799-A35EE573-83DC-45E4-96B1-E3960E12CA6BQ60529806-18CEFF19-5C15-4D5D-92D6-327D970DC181Q60529807-679F49D8-91D1-4C7F-BD12-9B2012352B7DQ60529808-EB3DD7A5-8914-4C18-9A8A-DFE5556948C7Q60529809-7E706387-DBA6-4A82-BF28-43D22892129CQ60529810-BFBE59D7-3B3E-4DB2-AF4E-BD4CF21C29CA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cathy B Moelans
@ast
Cathy B Moelans
@en
Cathy B Moelans
@es
Cathy B Moelans
@nl
Cathy B Moelans
@sl
type
label
Cathy B Moelans
@ast
Cathy B Moelans
@en
Cathy B Moelans
@es
Cathy B Moelans
@nl
Cathy B Moelans
@sl
prefLabel
Cathy B Moelans
@ast
Cathy B Moelans
@en
Cathy B Moelans
@es
Cathy B Moelans
@nl
Cathy B Moelans
@sl
P106
P21
P31
P496
0000-0001-9992-8703